BiotechTube
Home/TME Pharma/Aram Mangasarian
AM

Aram Mangasarian

CEO (inferred from conference speaker)

TME Pharma

Therapeutic Areas

OncologyGlioblastomaPancreatic Cancer

TME Pharma Pipeline

DrugIndicationPhase
NOX-A12 (olaptesed pegol)Glioblastoma (newly diagnosed, unmethylated MGMT)Phase 2
NOX-A12Pancreatic CancerPhase 2
NOX-E36Oncology (CCL2/MCP-1 target)Pre-clinical/Phase 1